Real World Evidence Clinical Utility Study of KidneyIntelX in Patients With Type 2 Diabetes and Chronic Kidney Disease
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
The purpose of this study is to assess the impact of the KidneyIntelX assay utilized as part of the current standard of care on the management of patients seen in the primary care physician's office at Mount Sinai.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 23
Healthy Volunteers: f
View:
• Individuals with Type 2 diabetes and concurrent chronic (diabetic) kidney disease (G3a-G3b or G1-G2, A2-A3) per KDIGO CKD staging.
Locations
United States
New York
Mount Sinai Health System
RECRUITING
New York
Contact Information
Primary
Roger Tun
rtun@renalytix.com
646-397-3970
Time Frame
Start Date: 2021-03-02
Estimated Completion Date: 2026-12-01
Participants
Target number of participants: 10000
Related Therapeutic Areas
Sponsors
Collaborators: Mount Sinai Hospital, New York
Leads: Renalytix AI, Inc.